We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
11751
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$57K ﹤0.01%
+1,728
New +$119K
RAIN
11752
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$57K ﹤0.01%
+10,362
New +$35.6K
FOA icon
11753
CALL
Finance of America Companies
FOA
$201M
$56K ﹤0.01%
3,560
+1,670
+88% +$38.6K
ICMB icon
11754
CALL
Investcorp Credit Management BDC
ICMB
$12.1M
$56K ﹤0.01%
+13,400
New +$63.8K
NEWP
11755
New Pacific Metals
NEWP
$1.27B
$56K ﹤0.01%
19,620
-3,103
-14% -$9.89K
NRDY icon
11756
CALL
Nerdy
NRDY
$90.4M
$56K ﹤0.01%
+26,300
New +$85.6K
HTT
11757
PUT
High Templar Tech Ltd
HTT
$393M
$56K ﹤0.01%
51,300
-9,100
-15% -$8.88K
SMMT icon
11758
CALL
Summit Therapeutics
SMMT
$10.6B
$56K ﹤0.01%
55,700
+42,600
+325% +$59.7K
VTSI icon
11759
PUT
VirTra
VTSI
$36.6M
$56K ﹤0.01%
11,400
-5,200
-31% -$26.5K
KYCHR
11760
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$56K ﹤0.01%
329,258
+7,258
+2% +$1.18K
INTZ
11761
CALL
DELISTED
INTRUSION INC NEW
INTZ
$56K ﹤0.01%
14,400
-44,800
-76% -$174K
AKBA icon
11762
CALL
Akebia Therapeutics
AKBA
$242M
$55K ﹤0.01%
156,200
-301,500
-66% -$127K
ATAI icon
11763
PUT
AtaiBeckley Inc
ATAI
$2.69B
$55K ﹤0.01%
15,200
-114,700
-88% -$469K
CUE icon
11764
CALL
Cue Biopharma
CUE
$233M
$55K ﹤0.01%
737
-280
-28% -$32.8K
MRDN
11765
Meridian Holdings Inc
MRDN
$181M
$55K ﹤0.01%
+1,024
New +$60K
KSCP icon
11766
Knightscope
KSCP
$30.6M
$55K ﹤0.01%
+366
New +$70.1K
LCTX icon
11767
Lineage Cell Therapeutics
LCTX
$271M
$55K ﹤0.01%
34,542
-21,461
-38% -$28.3K
ORIO
11768
CALL
Orion Digital Corp
ORIO
$20.1M
$55K ﹤0.01%
21,367
-4,333
-17% -$20.6K
NRXP icon
11769
NRX Pharmaceuticals
NRXP
$140M
$55K ﹤0.01%
+9,167
New +$120K
PLX icon
11770
CALL
Protalix BioTherapeutics
PLX
$179M
$55K ﹤0.01%
50,200
+14,500
+41% +$17K
SLNO
11771
DELISTED
Soleno Therapeutics
SLNO
$55K ﹤0.01%
19,687
+10,045
+104% +$27.8K
TAOX
11772
Tao Synergies Inc
TAOX
$25.7M
$55K ﹤0.01%
+433
New +$63.9K
VNRX icon
11773
CALL
VolitionRx Ltd
VNRX
$6.89M
$55K ﹤0.01%
1,350
-360
-21% -$18.1K
VTSI icon
11774
CALL
VirTra
VTSI
$36.6M
$55K ﹤0.01%
+11,200
New +$57.1K
AMBR
11775
Amber International Holding Ltd
AMBR
$124M
$55K ﹤0.01%
8,113
+6,634
+449% +$54.9K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.